Physician Assistant, Medical · Muskegon, MI
NPI
1740230200
Since 2006
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
0
Medicare group memberships
Hospitals
2
Hospital affiliations
5933 Grand Haven Rd
Muskegon, MI, 49441
Phone (231) 799-3300
Medicare paid, 2024
$39K
1,141 services
Medicare patients, 2024
99
Average age 64
Drug cost, 2024
$2.4M
12,728 prescriptions
Company payments, 2025
$10K
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David H Wilkins was code J3301 (injection, triamcinolone acetonide, not otherwise specified, 10 mg), 402 times for 33 patients. In total David H Wilkins billed 1,141 services in 37 codes, and Medicare paid $39K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-07-24.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 402 | 33 | $0.64 | $256 |
| 99214 Office E&M - Established | Office | 363 | 94 | $66.78 | $24K |
| 94060 Pulmonary Function Testing | Office | 109 | 39 | $19.48 | $2,123 |
| 20610 Joint Injection | Office | 35 | 21 | $35.93 | $1,258 |
| G0008 Administration of influenza virus vaccine | Office | 27 | 27 | $30.54 | $825 |
| 99215 Office E&M - Established | Office | 21 | 13 | $104.34 | $2,191 |
| 93000 Electrocardiogram | Office | 17 | 15 | $6.98 | $119 |
| 90661 Vaccine Product | Office | 16 | 16 | $36.11 | $578 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 13 | 13 | $163.97 | $2,132 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 13 | 13 | $104.06 | $1,353 |
| 90653 Vaccine Product | Office | 11 | 11 | $81.82 | $900 |
By year: 2022 $47K for 1,649 services; 2023 $46K for 1,554 services; 2024 $39K for 1,141 services.
Medicare prescription drug claims, 2024
In 2024, the drug David H Wilkins prescribed most often to Medicare patients was Rosuvastatin Calcium, with 845 prescriptions and refills. In total David H Wilkins wrote 12,728 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 845 | 1,528 | 189 | $12K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 633 | 633 | 94 | $13K |
| Omeprazole Generic | 311 | 619 | 82 | $3,805 |
| Quetiapine Fumarate Generic | 270 | 345 | 45 | $4,371 |
| Gabapentin Generic | 248 | 256 | 51 | $2,858 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 247 | 268 | 59 | $9,380 |
| Lisinopril Generic | 243 | 528 | 67 | $1,629 |
| Amitriptyline Hcl Generic | 213 | 283 | 40 | $2,453 |
| Glyxambi Empagliflozin/Linagliptin | 188 | 200 | 29 | $114K |
| Metformin Hcl Generic | 185 | 413 | 53 | $1,444 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 183 | 183 | 30 | $4,329 |
| Methadone Hcl Generic | 183 | 183 | 24 | $3,112 |
| Jardiance Empagliflozin | 175 | 253 | 39 | $138K |
| Levothyroxine Sodium Generic | 171 | 351 | 36 | $2,320 |
| Escitalopram Oxalate Generic | 164 | 193 | 29 | $1,002 |
Brand drugs: 2,718 claims; generic drugs: 9,924 claims; opioid claims: 1,172.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David H Wilkins $10K ($10K in general payments such as food, travel and fees) from 34 companies. The largest payer was Amgen Inc. with $6,369.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 18 | $6,369 |
| Abbvie Inc. ABBV | 42 | $620 |
| Supernus Pharmaceuticals, Inc. SUPN | 26 | $385 |
| Novo Nordisk Inc NVO | 16 | $295 |
| Pfizer Inc. PFE | 16 | $284 |
| Alkermes, Inc. ALKS | 12 | $283 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $215 |
| Axsome Therapeutics, Inc. AXSM | 7 | $193 |
| GlaxoSmithKline, LLC. GSK | 18 | $173 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 9 | $160 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.